SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Addiction Medicine Referral — Judy Garland — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Judy Garland |
|---|
| Date of birth | 1922-06-10 |
|---|
| Identifiers | MRN HR-ML005-SYN-TD; SSN (made up) 000-05-6127 |
|---|
| Document date | 1955-06-22 |
|---|
| Author | Margaret Ellsworth-Diaz, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Long-term dependence on prescribed secobarbital and dextroamphetamine that began with pills given to her as a teenage performer, in a 33-year-old singer three months after childbirth, with depression and anxiety. Please confirm the diagnoses and advise on a safe way to withdraw the barbiturate and stop the stimulant. [S]
Urgency: Within one week, on the same day as her one-week primary care visit. [S]
Questions for the consultant:
- Does she meet criteria for sedative-hypnotic and stimulant use disorders, given that these medicines were prescribed?
- How should the barbiturate be withdrawn safely: in hospital or as an outpatient, with which medicine, and at what pace?
- Should the stimulant be stopped, and at the same time as the barbiturate or afterwards?
- How should we treat her insomnia, depression and anxiety during the taper, and what should we avoid?
- Does she need naloxone, and what monitoring do you advise?
History of Present Illness
Given stimulant and sleeping pills since her teens; for years she has taken secobarbital 200 mg at bedtime, sometimes 300 mg, and dextroamphetamine 10 mg each morning with extra tablets on long working days, from three prescribers at two pharmacies, as the prescription drug monitoring program confirms. She has tried to cut down on her own and could not sleep. No opioids, benzodiazepines or pills from outside a pharmacy; urine drug test shows barbiturates and amphetamine only. No withdrawal seizures known. DAST-10 6, AUDIT-C 2. PHQ-9 14 (item 9 scored 0), GAD-7 13, Mood Disorder Questionnaire negative; structured safety assessment shows no current suicidal thoughts; suicide attempts were reported in earlier years. Third child born three months ago; not breastfeeding; pregnancy test negative. Pulse 98, blood pressure 128/84; ECG normal. Today: prescriptions moved to this clinic alone, seven days at a time; secobarbital continued at 200 mg at bedtime and dextroamphetamine at 10 mg each morning with no extra doses; sertraline 25 mg started; medroxyprogesterone injection given; CBT for insomnia and psychotherapy arranged. Blood test results from today attached [S]
- She wants to stop needing pills to sleep and to work, without being made to feel she is to blame for them. [S]
- She is afraid of being unable to sleep or perform during the change. [S]
- She worries about her weight if she stops the stimulant. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Judy Garland was born Frances Ethel Gumm on June 10, 1922, in Grand Rapids, Minnesota, to parents in vaudeville, and first appeared on stage as a small child. [D]
- She was signed by Metro-Goldwyn-Mayer at 13 and became a national star at 17 in The Wizard of Oz. [D]
- As a teenage studio performer she was given stimulant "pep pills" (amphetamines; Benzedrine is named) to suppress her appetite and keep up her energy through long working days, and sleeping pills (barbiturates; Seconal is named) so that she could sleep. She later described being given pills to stay on her feet and then being put to sleep with sleeping pills at the studio hospital. [D]
- Accounts differ on who first gave her the pills. A biography by Gerald Clarke reports that her mother gave her pills for energy and sleep in early childhood, before she joined the studio; other accounts attribute the pills to the studio and its doctors. [R]
- She struggled with dependence on prescribed medicines, stimulants and sleeping pills, for the rest of her life; by her twenties she was already dependent on pills. [D]
- Suicide attempts were reported publicly, including one in 1950; a biographical encyclopedia describes others in the 1940s and early 1950s. [D]
- In her twenties she was treated for what was publicly called exhaustion and spent periods in hospitals and sanitariums, including a stay at Peter Bent Brigham Hospital in Boston in 1949. [D]
- Her contract with Metro-Goldwyn-Mayer ended in 1950, and she returned to the stage in concert. [D]
- She starred in A Star Is Born, released in 1954, and was nominated for the Academy Award for Best Actress. [D]
- She gave birth to her third child, a son, in March 1955. [D]
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicine | Two capsules at bedtime; no extra doses | Oral route | 1955-06-22 to 1955-07-06 | completed | S |
| Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energy | One tablet each morning | Oral route | 1955-06-22 to 1955-07-20 | completed | S |
| Sertraline 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1955-06-22 to 1955-06-29 | completed | S |
| Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks | 150 mg intramuscularly every 13 weeks | Intramuscular route | 1955-06-22 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pills | active | confirmed |
F13.20 | S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis. |
| Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pills | active | confirmed |
F15.10 | S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription. |
| Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescence | active | confirmed |
G47.00 | S — Synthetic modern diagnosis anchored to the documented sleeping pills. |
| Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implants | active | confirmed |
Z30.013 | S — Synthetic contraception need; the birth is documented. |
| Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomania | active | confirmed |
F32.1 | S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used. |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| by 1939 | Stimulant pills for appetite and energy and barbiturate sleeping pills given to her as a teenage studio performer, with dependence on prescribed medicines since | D (CLM-0003, CLM-0005) |
| 1949 | Hospital and sanitarium stays in her twenties, publicly described as treatment for exhaustion | D (CLM-0007) |
| 1950 | Suicide attempts reported publicly, including one in 1950; recorded without detail | D (CLM-0006) |
| March 1955 | Birth of her third child three months before the index visit | D (CLM-0010) |
Family History
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
Social History
- Singer and actor who has performed since early childhood and worked for a film studio from 13; recently finished a major film; preparing for concert and television work, with long rehearsal days and late performances [S]
- Has been given pills for energy, appetite and sleep since she was a girl, and says she cannot remember sleeping without one; currently fills prescriptions from three prescribers at two pharmacies; no pills from any other source [S]
- Lives with her family, including a baby born three months ago; has help at home at night; not breastfeeding [S]
- Alcohol: a glass of wine about once a week (AUDIT-C 2); agrees to no alcohol while taking a barbiturate [S]
- Tobacco: about ten cigarettes a day; wants to deal with the pills first [S]
- Eats one real meal a day on working days and skips meals on the stimulant; worried about gaining weight because she has been told about her weight since childhood [S]
- Strengths: her work and her audience, her humor, wanting to be well for her children, and a close friend who knows about the pills [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1955-06-22 | Body height | 151 | cm | S |
| 1955-06-22 | Body weight | 46.5 | kg | S |
| 1955-06-22 | Body mass index (BMI) [Ratio] | 20.4 | kg/m2 | S |
| 1955-06-22 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1955-06-22 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1955-06-22 | Heart rate | 98 | /min | S |
| 1955-06-22 | Respiratory rate | 16 | /min | S |
| 1955-06-22 | Body temperature | 36.8 | Cel | S |
| 1955-06-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1955-06-22 | Hemoglobin [Mass/volume] in Blood | 12.3 | g/dL | 12-15.5 g/dL | Normal | S |
| 1955-06-22 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 86 | fL | 80-100 fL | Normal | S |
| 1955-06-22 | Platelets [#/volume] in Blood by Automated count | 284 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1955-06-22 | Ferritin [Mass/volume] in Serum or Plasma | 24 | ng/mL | 15-150 ng/mL | Normal | S |
| 1955-06-22 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1955-06-22 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1955-06-22 | Creatinine [Mass/volume] in Serum or Plasma | 0.66 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1955-06-22 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M | 119 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1955-06-22 | Glucose [Mass/volume] in Serum or Plasma | 82 | mg/dL | 70-99 mg/dL | Normal | S |
| 1955-06-22 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 10-35 U/L | Normal | S |
| 1955-06-22 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-35 U/L | Normal | S |
| 1955-06-22 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 5-40 U/L | Normal | S |
| 1955-06-22 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1955-06-22 | Total score [DAST-10] | 6 | {score} | | | S |
| 1955-06-22 | Total score [AUDIT-C] | 2 | {score} | | | S |
| 1955-06-22 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 14 | {score} | | | S |
| 1955-06-22 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 13 | {score} | | | S |
Assessment
- Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pills: active, confirmed [S]
- Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pills: active, confirmed [S]
- Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescence: active, confirmed [S]
- Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implants: active, confirmed [S]
- Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomania: active, confirmed [S]
Plan of Treatment
- Safe prescribing of controlled drugs: one prescriber and one pharmacy, a prescription drug monitoring program check before every controlled-substance prescription, a written shared treatment agreement, urine drug testing explained as part of care, seven-day supplies at first, a locked box, and take-back of unused capsules. Guideline: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025); Prescription Drug Monitoring Programs (PDMPs) (2026) [S]
- Insomnia: cognitive behavioral therapy for insomnia as first-line treatment, adapted to late performances (a fixed wake time, a wind-down routine after shows, sleep restriction only after the taper is stable), with a sleep diary; no new hypnotic. Guideline: Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline (2017); Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016) [S]
- Depression and anxiety: PHQ-9 and GAD-7 at each visit, sertraline, weekly psychotherapy, the Mood Disorder Questionnaire before the antidepressant, a structured safety assessment with a written safety plan, means safety and the 988 Suicide & Crisis Lifeline, and safety review at every visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) [S]
- Nutrition and weight without stigma: regular meals and snacks around rehearsals, a dietitian visit, no weight-loss target and no dieting drugs, and screening for disordered eating. Guideline: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) [S]
- Contraception that barbiturates do not weaken: medroxyprogesterone injection every 13 weeks, after a negative pregnancy test, with an intrauterine device as an alternative. Guideline: U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024) [S]
- Naloxone not prescribed: she takes no opioid, has no opioid prescription in the monitoring program, her urine test shows no opioids or fentanyl, and all her pills come from a pharmacy; naloxone does not reverse a barbiturate overdose. To be offered at once if an opioid is ever prescribed or any pill comes from outside a pharmacy. Guideline: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024); Prescription Drug Monitoring Programs (PDMPs) (2026) [S]
- Work: taper steps scheduled away from major performances, a written plan for late nights and travel, and letters she controls. Guideline: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) [S]
- Referral to addiction medicine, Tobias Grünewald, MD, ordered 1955-06-22 [S]